[Sign Up Now] to Receive Our FREE Daily SCVTV-SCVNews Digest by E-Mail

SCVNews.com | FDA Warns About Dietary Supplements, More | 03-14-2013
Inside
Weather
Santa Clarita CA
Clear
Clear
72°F
 
Calendar
Today in
S.C.V. History
August 17
1920 - Actress Maureen O'Hara born in Ireland; 1961 "Parent Trap" uses Disney Golden Oak Ranch [story]


fdamedwatchAfter products approved by the Food and Drug Administration (FDA) are on the market, the agency continues to monitor them for problems.

FDA encourages health care professionals and consumers to report problems with medical products, including

  • unexpected and undesirable side effects
  • quality problems, such as a drug with an unusual odor or color, or a device with defective parts
  • unclear or confusing instructions
  • failure to deliver the expected benefit.

Report problems to FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail, by fax, or by phone.

  • Online
  • Regular Mail: Use postage-paid, pre-addressed FDA form 3500
  • Fax: 800-FDA-0178
  • Phone: 800-332-1088

MedWatch reports can signal a safety problem and may lead to FDA action to protect the public from harm, serious illness or death.

Here are some of the most recent safety alerts and ongoing safety reviews prompted by reports FDA has received through MedWatch.

 

Caution Urged in Giving Kids Codeine

New actions are being taken to address a safety concern with codeine use in certain children after surgery to remove tonsils or adenoids (excess tissue in the throat) to treat sleep apnea. Deaths have occurred in children who received codeine for pain relief following these surgeries.

A new boxed warning, FDA’s strongest warning, will be added to the drug label of codeine-containing products about the risk of codeine to relieve pain in children following surgery to remove tonsils or adenoids. A contraindication (a formal way for FDA to make a strong recommendation against the use of a drug in certain patients) will be added to restrict codeine from being used in this setting. Other sections of the drug label will also be updated.

FDA first informed the public that it was reviewing the safety of codeine in children in August 2012 due to serious side effects and seven deaths in children who were given codeine after having their tonsils or adenoids removed. Since then, FDA’s comprehensive safety review identified six more children whose deaths between 1969 and May 1, 2012, were associated with codeine—many of them were given the drug after surgery to remove tonsils or adenoids, or to treat a respiratory tract infection.

Risk: Most of these children, ages 21 months to 9 years, showed evidence of being ultra-rapid metabolizers, an inherited ability to convert codeine into life-threatening amounts of morphine in the body. High levels of morphine can lead to potentially fatal breathing difficulties.

Recommendations

  • If your child’s health care professional prescribes codeine after surgery to remove tonsils or adenoids, ask for another pain medicine.
  • If codeine is prescribed for other types of pain, it is often given on an “as needed” basis. Do not give codeine to a child on a scheduled basis unless the child requires the drug, as determined by a health care professional. Do not give more than six doses per day.
  • If your child shows signs of serious side effects of codeine (unusual sleepiness, confusion, or difficult or noisy breathing), stop giving codeine and immediately take your child to the emergency room or call 911.

For More Information

 

Recall: Anemia Drug Omontys Due to Reactions, Deaths

Omontys (peginesatide) Injection has been recalled because of reports of severe allergic reactions—including death—that occurred within 30 minutes after a small percentage of patients received their first dose of the drug through a vein (intravenously). The manufacturer of the drug said there have been no reports of subsequent serious reactions from patients who tolerated the initial dose, or from patients who have completed their dialysis treatment but are still taking the medication.

Omontys is used to treat anemia due to chronic kidney disease in adult dialysis patients. The drug is packaged in 10 mg and 20 mg multi-dose vials and distributed to dialysis centers nationwide, including Puerto Rico and Guam.

Additional products that stimulate the formation of red blood cells are available to treat anemia, including Procrit, Epogen and Aranesp.

Risk: According to the companies who represent Omontys, Affymax Inc. and Takeda Pharmaceutical Company Ltd., about 0.2 percent (about 50) of the 25,000 patients who received the drug after it was approved in March 2012 have reported some allergic reaction, with about a third of these reactions being serious. About 0.02 percent (about 5) of the 25,000 died after getting their first dose of the drug.

Recommendation: If you have any questions about Omontys, talk to your health care professional or call the manufacturer at 855-466-6689 Monday through Friday from 9 a.m. to 5 p.m. ET.

For More Information

 

 

Recall: Reumofan Products Due to Hidden Drug Risk

FDA continues to warn the public about Reumofan Plus—a product promoted as a dietary supplement for the treatment of arthritis, osteoporosis, bone cancer and other conditions. The product contains hidden prescription drug ingredients that can cause potentially fatal side effects. It could be labeled in Spanish and sold in some retail outlets, at flea markets and on the Internet.

This latest alert is for Reumofan Plus Tablets, Lot Number 99515, expiration date of 09/16.

Risk: Since June 2012, when FDA first warned the public about the dangers of Reumofan Plus and Reumofan Plus Premium, the agency has received reports of fatalities, stroke, dizziness, difficulty sleeping, high blood sugar levels, problems with liver and kidney functions, and severe bleeding in the esophagus, stomach and intestines, as well as corticosteroid (an anti-inflammatory drug) withdrawal syndrome.

FDA has analyzed the products and found the following drug ingredients:

  • methocarbamol—a prescription muscle relaxant that can cause sedation, dizziness, low blood pressure and impairment of the ability to perform tasks such as driving a motor vehicle
  • dexamethasone—a corticosteroid that can increase the risk of infection and cause increased blood sugar levels, changes in blood pressure, damage to bones and psychiatric problems
  • diclofenac sodium—a prescription non-steroidal anti-inflammatory drug (NSAID) that may cause an increased risk of cardiovascular events, such as heart attack and stroke, as well as serious stomach and intestinal problems including  bleeding, ulceration and fatal perforation (small hole) of the stomach and intestines.

Recommendations

If you are currently taking or recently stopped taking these products, talk to a health care professional immediately. If you stop taking corticosteroids (such as dexamethasone found in Reumofan products) after long-term use, or after taking high doses, you run the risk of suffering from withdrawal syndrome. You should work with a health care professional to slowly and safely taper off the drug.

For More Information

Recall: Vistide Injection Due to Foreign Particles

Gilead Sciences Inc. is recalling one lot (B120217A) of Vistide (cidofovir injection) due to foreign particles found in some vials of this lot.

Vistide is used to treat cytomegalovirus retinitis (an infection in the eye that can cause blindness) in people with AIDS. This sterile, colorless solution is injected into the vein (intravenously) and is typically given in a hospital or doctor’s office.

Recommendation: Tell your doctor or other health care professional if you have experienced any problems after receiving Vistide.

For More Information

Vistide (Cidofovir Injection) by Gilead: Recall – Presence of Particulate Matter

Recall: Maxiloss Weight Advanced Softgels Due to Hidden Drug

Olaax Corp. has recalled its product promoted as a dietary supplement under the brand name Maxiloss Weight Advanced Softgels because FDA testing found it contains sibutramine, a controlled substance that was removed from the market in October 2010 for safety reasons.

Maxiloss Weight Advanced Softgels are marketed as a natural herb for weight loss. The recall includes all lot numbers of both the authentic product and counterfeit versions of the product that have been found.

Any packaging types that are different from the authentic product are counterfeit. The authentic product is packaged in a green or blue box containing 3 x 12 blister packs per box and bearing “Batch Number: 001.” The product was sold to distributors nationwide in the U.S. from January 2011 to November 2012. Versions known to be counterfeit are sold on various online sites.

Risk: Sibutramine is known to substantially increase blood pressure or pulse rate in some people, and may present a significant risk to patients with a history of heart disease or stroke. This product may also interact in life-threatening ways with other medications.

Recommendations

  • Stop using this product and throw it away.
  • Contact your doctor or other health care professional if you have taken this product and experienced any problems.
  • If you have questions on this recall, contact Olaax Corp. at 863-648-9581 Monday through Friday from 9 a.m. to 5:30 p.m. ET.

For More Information

 

Recall: Z Pro High Protein Supplement Due to Allergens Not Listed on Label

R-Kane Products Inc. has recalled its Z Pro High Protein Supplement because it contains soy and milk, allergens that are not listed on the labels of individual packets of this product.

The supplement was distributed nationwide between Jan. 1, 2006, and Jan. 24, 2013, to facilities and health care professionals who gave the product to patients who underwent bariatric (weight loss) surgery.

The recall followed an FDA inspection that found that these allergens were not listed on the inner packets of the product—only on the outer box containing 24 individual packets. Products shipped after Jan. 24, 2013, contain the allergen disclosure on individual packets.

Risk: People who have an allergy or severe sensitivity to soy or milk run the risk of a serious or life-threatening allergic reaction if they consume this product.

Recommendation: You can get information on what to do with the product by calling Robert Kaskey at 856-663-0644 Monday through Friday from 10 a.m. to 4 p.m. ET.

For More Information

Z Pro High Protein Supplement: Recall – Undeclared Soy and Milk

 

Drug Safety Labeling Changes

In January 2013, FDA required safety labeling changes to be made to 27 drugs, including the antidepressant Prozac (fluoxetine HCl) and the antibiotics Cipro (ciprofloxin) and Augmentin (amoxicillin/clavulanate potassium).

In general, changes were made to the prescribing information and, in some cases, to the patient package inserts and medication guides (paper handouts for patients that come with many prescription medicines) to warn about potential harmful reactions, tell who shouldn’t take the drug, or give other safety information.

For More Information

Monthly Safety Labeling Changes

 

Comment On This Story
COMMENT POLICY: We welcome comments from individuals and businesses. All comments are moderated. Comments are subject to rejection if they are vulgar, combative, or in poor taste.
REAL NAMES ONLY: All posters must use their real individual or business name. This applies equally to Twitter account holders who use a nickname.

0 Comments

You can be the first one to leave a comment.

Leave a Comment


SCV NewsBreak
Loading...
Related Content
LOCAL NEWS HEADLINES
Thursday, Aug 17, 2017
San Francisquito Road Collision Leads to Major Injuries
Two people have been hospitalized with major injuries after a collision on San Francisquito Wednesday night.
Thursday, Aug 17, 2017
More Than 30 Caltrans “Fix-it-First” Projects Accelerated by SB 1
Caltrans today announced that 32 major “fix-it-first” transportation projects can be accelerated a year earlier than planned thanks to anticipated funding from Senate Bill 1 (SB 1), the Road Repair and Accountability Act of 2017.
Thursday, Aug 17, 2017
CSUN President Releases Statement on Charlottesville
Statement from CSUN President Dianne F. Harrison on Recent Events in Charlottesville, Virginia
Keep Up With Our Facebook

Latest Additions to SCVNews.com
The storewide remodel of the Walmart Supercenter at 26471 Carl Boyer Drive is complete and, in addition to the many physical changes inside, Santa Clarita residents now have access to Online Grocery Pickup.
Walmart on Carl Boyer Drive Celebrates Grand Reopening Friday
Tonight on SCV NewsBreak, two people have been hospitalized after a major collision. Plus, an acquisition of land near the 14. Watch these stories and more on tonight's edition of SCV NewsBreak.
SCV NewsBreak for Thursday August 17, 2017
Le Chene French Cuisine, a long-time Santa Clarita local favorite restaurant along Sierra Highway, has announced that they will be hosting a thrilling Murder Mystery Dinner on Saturday, November 4th, 2017.
Nov. 4: Le Chene Murder Mystery Dinner
Senator Scott Wilk, R- Antelope Valley, today announces that he is one of the 2017 inductees into the Antelope Valley High School Alumni Hall of Fame.
Sept. 22: Wilk to be Inducted into AV High School Hall of Fame
Signups are under way for the Santa Clarita Walk to End Alzheimer’s, which offers participants an opportunity to take a healthy stroll, experience outstanding live entertainment, honor loved ones who have been affected by Alzheimer’s and raise funds to battle the debilitating disease.
Oct. 7: Walk to End Alzheimer’s; Signups Underway
According to the South Coast Air Quality Management District, air quality will be unhealthy for sensitive individuals in Santa Clarita Valley Friday.
AQMD: Unhealthy Air Quality Forecasted for SCV Friday
Trammell Crow Company (TCC) andand Clarion Partners are pleased to announce the acquisition of 54 acres of land for the development of The Center at Needham Ranch, a state-of-the-art business park in the city of Santa Clarita, CA.
TCC, Clarion Partners Acquire More Than 50 Acres of SCV Real Estate
The California Department of Tax and Fee Administration is hosting what will be a highly educational and informative (and free) Tax Seminar for Nonprofits and Exempt Organizations.
Sept. 6: Tax Seminar for Non-Profits and Exempt Organizations
For the first time in 99 years, a total eclipse of the sun will pass over the continental United States on August 21, and Princess Cruises guests sailing on six cruise ships in Alaska will be invited to special viewing parties as part of the cruise line’s exclusive Stargazing with Discovery at Sea program.
Princess Cruises to Host On-Board Viewing Parties for Solar Eclipse
Two people have been hospitalized with major injuries after a collision on San Francisquito Wednesday night.
San Francisquito Road Collision Leads to Major Injuries
Caltrans today announced that 32 major “fix-it-first” transportation projects can be accelerated a year earlier than planned thanks to anticipated funding from Senate Bill 1 (SB 1), the Road Repair and Accountability Act of 2017.
More Than 30 Caltrans “Fix-it-First” Projects Accelerated by SB 1
Statement from CSUN President Dianne F. Harrison on Recent Events in Charlottesville, Virginia
CSUN President Releases Statement on Charlottesville
The Los Angeles County Fire Department responded to a traffic collision at Bouquet Canyon and Plum Canyon Roads early Thursday morning.
Firefighters Extricate Trapped Person After Early Morning Collision
Brandon Gold allowed a tie-breaking home run in the sixth inning and the Lancaster JetHawks fell to the San Jose Giants, 4-2, on Wednesday night at Municipal Stadium.
Gold, JetHawks Fall Short Against the Giants
In comments submitted Thursday, Attorney General Xavier Becerra expressed his strong opposition to any attempt by the Trump Administration to open California’s coast to new offshore drilling.
Becerra Vows to Protect State from Offshore Drilling
While Charlottesville violence and protests continue divisive dialogue nationally, Santa Clarita residents gathered to create a place “to be able to come together.”
Community Members Hold Vigil for Charlottesville
1920 - Actress Maureen O'Hara born in Ireland; 1961 "Parent Trap" uses Disney Golden Oak Ranch [story]
Farmers and environmentalists are lining up to battle the $16.7 billion California WaterFix tunnels project proposed for the Sacramento-San Joaquin River Delta.
Farmers, Environmentalists Join to Fight California ‘WaterFix’ Project
There's a new Grizzly at Golden Valley High School as Matt Sorensen has been named the school's new head baseball coach.
Matt Sorenson New Head Baseball Coach at Golden Valley
Tonight on SCV NewsBreak, Sheriff’s deputies are continuing to conduct burglary suppression operations in our valley. Plus, Representative Steve Knight sat down with local law enforcement to discuss the current state and future role of policing in the SCV. Watch these stories and more on tonight's edition of SCV NewsBreak.
SCV NewsBreak for Wednesday, August 16, 2017
The Saugus Union School Board is establishing a committee to advise on the development of policies and procedures for the sale or lease of surplus real property owned by the District.
Saugus Board Creates Surplus Property Advisory Committee
The SCV Sanitation Board has provided an update in its efforts to comply with the state-mandated chloride limit, including finalizing the Recirculated EIR released for public comment in May.
SCV Sanitation Board Finalizing EIR Due August 18
"Music, Volume 1," the latest album by platinum recording artist and CalArts' School of Music namesake Herb Alpert, recently reached the No. 1 spot on the Billboard Contemporary Jazz Albums chart.
Herb Alpert’s Latest Album Tops Billboard Jazz Chart
The Castaic Union School District's Governing Board will hold a special meeting on Thursday, August 17 at 5 p.m.
August 17: Castaic Schools Governing Board Special Meeting
MannKind Corp. is moving its corporate headquarters to Westlake Village, after nearly 17 years in Valencia, according to the latest quarterly report it filed with the SEC.
MannKind Corp. Moving from Valencia to Westlake Village
CalArts grads Mark Bradford and Sharon Lockhart headline the Un-Private Collection artist talk at the Orpheum Wednesday night, presented by the Broad museum of contemporary art.
August 16: CalArtians Mark Bradford, Sharon Lockhart at Broad in L.A.
Santa Clarita Valley International School has hired veteran coach Ken Erenberg as athletic director, the school announced today.
Ken Erenberg Named SCVi Athletic Director
The Los Angeles Dodgers took the first of the two-game Interleague series with a 6-1 victory over the White Sox at Dodger Stadium Tuesday night.
Dodgers Soil White Sox 6-1 Tuesday
40 oz. to Freedom arrives in Santa Clarita as part of its anniversary tour at Concerts in the Park at Central Park on Saturday, August 19, with showtime at 7 p.m.
August 19: 40 Oz. to Freedom Rocks Central Park
Senator Scott Wilk, R- Antelope Valley, today submitted a letter to the California Department of Corrections and Rehabilitation during a public comment period regarding proposed regulations that could lead to the early release of dangerous "nonviolent" inmates and diminish victim rights.
Wilk Urges Public Safety When Releasing ‘Non-Violent’ Felons
The Los Angeles County Commission on Human Relations released a statement Wednesday morning, condemning the violence and mourning a death in Charlottesville.
County Commission Mourns Death of Charlottesville Protester
Garrett Hampson, the Cal League’s reigning Player of the Week, slugged a two-run home run to lead the Lancaster JetHawks to a 5-3 win over the San Jose Giants on Tuesday night at Municipal Stadium.
Hampson Stays Hot, Lifts ‘Hawks Over Giants
Santa Clarita Valley Sheriff's Station deputies arrested three suspects and seized drugs and weapons in a recent burglary suppression operation.
SCV Deputies Arrest 3, Seize Drugs, Weapons
1947 - Newhall Hardware opens on Spruce Street, now called Main Street [story]
Representative Steve Knight, R-Palmdale, sat down with Santa Clarita law enforcement officials to discuss the current state and future role of policing in the SCV.
Knight, Law Enforcement Officials Hold Roundtable Discussion